Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Peter O'Donnell, MD
<< Back to Our Featured Experts
Dr. O'Donnell on Challenges With PD-L1 Testing in Bladder Cancer
Dr. O'Donnell on the Importance of Identifying Molecular Subsets in Urothelial Cancer
Dr. O'Donnell on Ongoing Immunotherapy Trials in Bladder Cancer
Dr. O'Donnell on PD-L1 Testing in Bladder Cancer
Dr. O'Donnell Compares Checkpoint Inhibitors in Bladder Cancer
Dr. O'Donnell on the Evolution of Immunotherapy in Metastatic Bladder Cancer
Dr. Peter O'Donnell on Atezolizumab and IMvigor 210
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Susan M. O'Brien, MD
Susan M. O'Brien
Juan Manuel O'Connor, MD
Kathleen L. O'Connor, MD
Owen O'Connor, MD, PhD
Owen O'Connor
Peter O'Donnell, MD
Jill O'Donnell-Tormey, PhD
Mark H. O'Hara, MD
David O'Malley, MD
Bert O'Neil, MD
Bert H. O'Neil, MD
Brock O'Neil, MD
Bert O'Neil
Ruth O'Regan, MD
Ruth M. O'Regan, MD
Eileen O'Reilly, MD
Eileen M. O'Reilly, MD
Eileen O'Reilly
Joyce O'Shaughnessy, MD
Joyce A. O'Shaughnessy
Ciara O'Sullivan, MB, BCh
Ana Oaknin, MD
Elias Obeid, MD, MPH
Paul E. Oberstein, MD
Susan M. OBrien, MD
Allyson Ocean, MD
Owen A. OConnor, MD, PhD
Anobel Odisho, MD
Peter ODonnell, MD
Steffi Oesterreich, PhD
Michael D. Offin, MD
William Oh, MD
William K. Oh, MD
Stephen Oh, MD, PhD
Ted Okon
Colleen OLeary, MSN
Gustavo Olivera, PhD
Carl Olsson, MD
Anthony J. Olszanski, MD, RPh
Ruth M. ORegan, MD
Moshe Ornstein, MD
Robert D. Orzechowski, MBA
Raymond U. Osarogiagbon, MD, FACP
C. Kent Osborne, MD
Joyce A. OShaughnessy, MD
Eric M. Ostertag, MD, PhD
Joe OSullivan, MD
Patrick Ott, MD, PhD
Sai-Hong I. Ou, MD
Sai-Hong I. Ou, MD, PhD
Sai-Hong Ignatius Ou, MD, PhD
Michael J. Overman, MD
Beth Overmoyer, MD
Willem Overwijk, PhD
Geoffrey R. Oxnard, MD
Randall A. Oyer, MD
Bert ONeil, MD
Joyce A. OShaughnessy, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
Dr. Wierda on Chemoimmunotherapy in CLL
Dr. Oh on Remaining Challenges in mHSPC
FDA Panel to Review Olaparib Application in Metastatic Pancreatic Cancer
Idecabtagene Vicleucel Meets ORR Endpoint in Relapsed/Refractory Multiple Myeloma
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe